Track and Trace Solutions Hold Largest Share of the Global Track and Trace Solutions Market

Track and Trace Solutions Market



Market Overview:

Track and trace solutions provide serialization and aggregation of products at individual item level to track them across the supply chain. These solutions help to tackle issues related to counterfeit medicines, reduce theft and improve supply chain transparency.

Market key trends:
One of the key trends driving the track and trace solutions market is the implementation of regulations mandating serialization. Stringent regulations such as Drug Supply Chain Security Act (DSCSA) in the US and Falsified Medicines Directive (FMD) in Europe require implementation of track and trace solutions. Pharmaceutical manufacturers are widely adopting these solutions to comply with the regulations and curb illegal practices like drug counterfeiting. Furthermore, growing medical applications of unique device identification will further propel the market growth over the forecast period.
Segment Analysis

The Track And Trace Solutions Market Demand is segmented by product into software, hardware, and standalone products. The software segment dominated the market in 2022 and is expected to maintain its dominance over the forecast period. Software segment accounts for over 50% of the total market share as software forms an integral part of track and trace solutions which help in storing and managing serialized data to track individual products throughout the supply chain.

Key Takeaways

The global track and trace solutions market is expected to witness high growth, exhibiting CAGR of 14.79% over the forecast period, due to increasing regulations regarding serialization and aggregation of pharmaceutical products.

Regional analysis

North America dominated the track and trace solutions market in 2022 and is expected to maintain its position over the forecast period. Presence of key players and stringent regulations for serialization of drugs and monitoring medical devices propel the growth of track and trace solutions in the region. Asia Pacific is expected to witness the highest growth rate owing to rising pharmaceutical industry and increasing adoption of track and trace solutions across industries in emerging economies like China and India.

Key players

Key players operating in the track and trace solutions market are Tracelink Inc., Adents International, Seidenader Maschinenbau Gmbh., Axway Software Sa, Siemens Ag, Mettler Toledo International Inc., Robert Bosch Gmbh, and Optel Group. Tracelink Inc. held the leading market share in 2022 owing to its comprehensive software portfolio to trace products throughout the supply chain.

Read More:

https://www.dailyprbulletin.com/track-and-trace-solutions-market-demand/

Comments

Post a Comment

Popular posts from this blog

Precast Concrete Market Is Estimated To Witness High Growth Owing To Increasing Demand for Sustainable Construction Practices

Image
Precast Concrete Market Market Overview: The Precast Concrete Market is witnessing significant growth due to the increasing demand for sustainable construction practices. Precast concrete products are prefabricated in controlled factory conditions, offering several advantages such as improved quality control, reduced construction time, and increased durability. These products are widely used in residential, commercial, and infrastructure projects due to their ability to enhance construction efficiency and productivity. With the growing need for energy-efficient and environmentally friendly buildings, the demand for precast concrete products is expected to rise. Market Key Trends: One key trend in the Precast Concrete Market is the adoption of advanced technology in manufacturing processes. The use of computer-aided design (CAD) and building information modeling (BIM) is enabling manufacturers to produce complex and customized precast concrete products with high precision. Additional
Read more

Relapsed Or Refractory Diffuse Large B Cell Lymphoma Market Growth driven by increased adoption of targeted therapies

Image
Relapsed Or Refractory Diffuse Large B Cell Lymphoma Market Market Overview: Relapsed Or Refractory Diffuse Large B Cell Lymphoma (R/R DLBCL) is an aggressive fast-growing type of non-Hodgkin's lymphoma (NHL) cancer that generally affects immune system cells called B cells. DLBCL can occur at any age but is most common in older adults. Novel targeted therapies like chimeric antigen receptor (CAR) T-cell therapies, bispecific antibodies and antibody-drug conjugates are revolutionizing the treatment of R/R DLBCL. These advanced therapies are offering new hope to patients by increasing survival rates. Market key trends: One of the key trends in the R/R DLBCL market is the increasing adoption of CAR T-cell therapies. CAR T-cell therapy is an innovative new approach to treating R/R DLBCL through the use of genetically engineered T-cells. Drugs like Kymriah and Yescarta have proven highly effective in treating certain patients with relapsed or refractory forms of large B-cell lymphoma.
Read more

The global Biopharmaceuticals Market connected with therapeutic biologics

Image
Biopharmaceuticals Market Market Overview: The biopharmaceuticals market comprises medicines produced using biotechnology methods like genetic engineering and includes vaccines, blood components, recombinant therapeutic proteins/antibodies, and monoclonal antibodies. Biopharmaceuticals are often used for treating serious medical conditions like cancer, autoimmune diseases, and other chronic disorders. These drugs provide targeted treatment options and have lesser side effects than traditional small-molecule drugs. The market is witnessing high demand due to increasing prevalence of chronic diseases and growing geriatric population globally. Market key trends: One of the key trends gaining traction in The Biopharmaceuticals Market Demand is the increasing adoption of biosimilars. Biosimilars are quasi-generic versions of original biologics and provide more affordable treatment options when the patents of biologics expire. Regulatory agencies in various regions are also approving bios
Read more